Engineered Microorganisms for Methacrylic Acid Biosynthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing methacrylic acid and its precursors, such as methacrylic acid, 2-hydroxyisobutyrate, and 3-hydroxyisobutyrate, face challenges including the handling of hazardous chemicals and high disposal costs, necessitating the development of cleaner and more economical processes.

Innovation Solution

Design and production of non-naturally occurring microbial organisms with engineered methacrylic acid pathways, allowing for the biosynthesis of methacrylic acid and its precursors through metabolic engineering, utilizing exogenous nucleic acids encoding enzymes involved in these pathways, enabling the organisms to produce these compounds from renewable sugar feedstocks.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If conventional acetone cyanohydrin route is used to produce methacrylic acid, then production efficiency is maintained, but handling of hazardous HCN and high disposal costs of ammonium bisulfate byproducts create safety and environmental problems

Engineering Contradiction:
Improvehazardous chemical handling and byproduct disposalVSAvoidproduction efficiency
Core Design Contradiction:
Object-affected harmful factorsVSProductivity

Solution Approach 1:

The patent replaces conventional chemical catalysis with enzymatic catalysis. Specifically, it uses engineered microorganisms expressing enzymes such as 3-hydroxyisobutyrate dehydratase to catalyze the conversion of sugar feedstocks to methacrylic acid, substituting the mechanical/chemical process with a biological system that avoids hazardous chemicals and simplifies byproduct management

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the fundamental parameters of the production system by switching from petrochemical feedstocks (acetone, hydrogen cyanide) to renewable sugar feedstocks. This parameter change transforms the entire reaction pathway, eliminating the need for hazardous intermediates like acetone cyanohydrin and producing benign byproducts instead of ammonium bisulfate

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If new cleaner processes are developed to eliminate hazardous chemicals, then safety and environmental performance improve, but process complexity and development costs increase

Engineering Contradiction:
Improvehazardous chemical eliminationVSAvoidprocess complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The engineered microorganisms perform multiple functions within a single biological system: they consume renewable sugar feedstocks, convert them through engineered metabolic pathways to produce methacrylic acid, and simultaneously manage their own catalytic functions through expressed enzymes. This self-contained biological system eliminates the need for separate hazardous chemical handling and disposal infrastructure

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The engineered microorganism serves multiple purposes: it acts as the feedstock processor, the catalytic converter, and the production platform simultaneously. The single biological system replaces multiple separate chemical processing units, reducing overall process complexity despite the sophistication of the genetic engineering involved

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Ease of manufacture

If biosynthetic pathways are engineered into microorganisms to produce methacrylic acid from sugars, then environmental friendliness and economic viability improve, but the complexity of metabolic engineering and pathway optimization increases

Engineering Contradiction:
Improveeconomic viability and sustainabilityVSAvoidmetabolic engineering complexity
Core Design Contradiction:
Ease of manufactureVSDevice complexity

Solution Approach 1:

The patent divides the complex biosynthetic pathway into discrete enzymatic steps, each catalyzed by a specific engineered enzyme. The pathway is segmented into: (1) sugar uptake and phosphorylation, (2) conversion to 3-hydroxyisobutyrate intermediates, and (3) dehydration to methacrylic acid. This segmentation allows for targeted enzyme engineering and optimization of individual pathway steps rather than attempting to optimize the entire system at once

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses engineered enzymes as intermediaries to bridge the gap between renewable sugar feedstocks and the target product methacrylic acid. Specific enzyme intermediaries such as 3-hydroxyisobutyrate dehydratase catalyze the rate-determining steps, enabling the conversion without requiring direct contact between the biological system and the final chemical product, thus simplifying downstream processing

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables high-yielding, economically viable, and environmentally friendly production of methacrylic acid and its precursors, reducing the need for hazardous chemicals and minimizing disposal costs, while providing a sustainable method for industrial-scale production.

Implementation Method 1

The non-naturally occurring microbial organism is capable of metabolizing a renewable sugar feedstock to produce methacrylic acid

Methodology Applied
Scientific EffectFermentation: Fermentation

Implementation Method 2

The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in a methacrylic acid pathway

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentUS9951355B2Microorganisms for the production of methacrylic acid
Publication Date: 2018.04.24 GENOMATICA INC
  • US9951355B2 patent drawing
  • US9951355B2 patent drawing
  • US9951355B2 patent drawing

AI summary

The invention provides a non-naturally occurring microbial organism having a 2-hydroxyisobutyric acid, 3-hydroxyisobutyric acid or methacrylic acid pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in a 2-hydroxyisobutyric acid, 3-hydroxyisobutyric acid or methacrylic acid pathway. The invention additionally provides a method for producing 2-hydroxyisobutyric acid, 3-hydroxyisobutyric acid or methacrylic acid. The method can include culturing a 2-hydroxyisobutyric acid, 3-hydroxyisobutyric acid or methacrylic acid producing microbial organism expressing at least one exogenous nucleic acid encoding a 2-hydroxyisobutyric acid, 3-hydroxyisobutyric acid or methacrylic acid pathway enzyme in a sufficient amount and culturing under conditions and for a sufficient period of time to produce 2-hydroxyisobutyric acid, 3-hydroxyisobutyric acid or methacrylic acid.